Professor Kenneth Shadlen questions whether patents and the global race to develop vaccines and treatments for Covid-19 will hinder access to the products it generates.
The Covid-19 pandemic has sparked a global race of public- and private-led research to develop vaccines and treatments. Will patents hinder access to the products it generates?
My summary? With regard to treatments (the dynamics around vaccines may […]